Literature DB >> 31042521

The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology.

Güliz A Barkan1, Eva M Wojcik2, Ritu Nayar3, Spasenija Savic-Prince4, Marcus L Quek5, Daniel F I Kurtycz6, Dorothy L Rosenthal7.   

Abstract

The main purpose of urine cytology is to detect high-grade urothelial carcinoma (HGUC). With this principle in mind, The Paris System (TPS) Working Group, composed of cytopathologists, surgical pathologists, and urologists, has proposed and published a standardized reporting system that includes specific diagnostic categories and cytomorphologic criteria for the reliable diagnosis of HGUC. This paper outlines the essential elements of TPS and the process that led to the formation and rationale of the reporting system. The Paris System Working Group, organized at the 2013 International Congress of Cytology, conceived a standardized platform on which to base cytologic interpretation of urine samples. The widespread dissemination of this approach to cytologic examination and reporting of urologic samples and the scheme's universal acceptance by pathologists and urologists is critical for its success. For urologists, understanding the diagnostic criteria, their clinical implications, and the limitations of TPS is essential if they are to utilize urine cytology and noninvasive ancillary tests in a thoughtful and practical manner. This is the first international/inclusive attempt at standardizing urinary cytology. The success of TPS will depend on the pathology and urology communities working collectively to improve this seminal paradigm shift, and optimize the impact on patient care.
Copyright © 2016 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Standardized reporting terminology; The Paris System; Urine

Year:  2016        PMID: 31042521     DOI: 10.1016/j.jasc.2016.04.005

Source DB:  PubMed          Journal:  J Am Soc Cytopathol        ISSN: 2213-2953


  6 in total

1.  Diagnostic role of urine cytology and ureteroscopic biopsies in detection of high grade upper tract urothelial carcinoma.

Authors:  Yani Zhao; Fang-Ming Deng; Jonathan Melamed; William C Huang; Hongying Huang; Qinghu Ren
Journal:  Am J Clin Exp Urol       Date:  2021-06-15

Review 2.  Bladder cancer detection in patients with neurogenic bladder: are cystoscopy and cytology effective, and are biomarkers pertinent as future diagnostic tools? A scoping review.

Authors:  Marc Sbizzera; Françoise Descotes; Théo Arber; Paul Neuville; Alain Ruffion
Journal:  World J Urol       Date:  2022-02-04       Impact factor: 3.661

3.  Educational Case: Urothelial Carcinoma: An Overview of Pathologic Diagnosis.

Authors:  Jonathan Willner; Ammar Matloob; Anges Colanta; Samer N Khader
Journal:  Acad Pathol       Date:  2020-09-30

4.  Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?

Authors:  Thorsten H Ecke; Thomas Otto; Florence Le Calvez-Kelm
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

5.  Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles.

Authors:  Jinshan Xu; Shuxiong Zeng; Jun Li; Li Gao; Wenjun Le; Xin Huang; Guandan Wang; Bingdi Chen; Zhensheng Zhang; Chuanliang Xu
Journal:  Front Cell Dev Biol       Date:  2022-01-31

6.  Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.

Authors:  Alexandros Pergaris; Dimitra Stefanou; Panagiota Keramari; Stylianos Sousouris; Nikolaos Kavantzas; Helen Gogas; Panagiota Mikou
Journal:  Diagnostics (Basel)       Date:  2021-11-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.